Pubblicazioni

Approfondimenti generali

: American Society of Clinical Oncology (ASCO) [Apri]
: Neoplasie della mammella, Linee Guida AIOM, 2018 [Apri]
: ESMO Clinical Practice Guidelines: Breast Cancer [Apri]
: ClinicalTrial.gov. A service of the U.S. National Institutes of Health [Apri]

Referenze bibliografiche specifiche

: LoRusso PM, et al. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer. Clin Cancer Res. 2011;17:6437-6447 [Apri]
: Verma S, et al. Trastuzumab emtansine for HER2-positive advanced breast cancer. N Engl J Med 2012;367:1783-1791 [Apri]
: Giordano SH, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor 2-positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2014;32:2078-2099 [Apri]